Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy.
D000115:Acetylesterase / Q000378:metabolism; D000208:Acute Disease; D000437:Alcoholism / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001463:Barbiturates / Q000494:pharmacology; D001663:Bilirubin / Q000097:blood; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006505:Hepatitis / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D007538:Isoniazid / Q000378:metabolism*; D008107:Liver Diseases / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism*; D008111:Liver Function Tests; D008861:Microsomes / Q000201:enzymology; D010653:Phenylbutazone / Q000378:metabolism*; D011241:Prednisone / Q000494:pharmacology; D012709:Serum Albumin / Q000032:analysis
D001463:Barbiturates; D006634:Histamine H1 Antagonists; D012709:Serum Albumin; D001219:Aspartate Aminotransferases; D000115:Acetylesterase; D000469:Alkaline Phosphatase; D010653:Phenylbutazone; D001663:Bilirubin; D007538:Isoniazid; D011241:Prednisone